Robert Gagnon sold $50K of Opus Genetics stock
By AlphaYouPublished Form 4
Gagnon Robert E.
Reporting filer
Robert Gagnon reported selling 14,000 shares of Opus Genetics, Inc. for about $50K ($3.55 a share on average). Form 4 filed Oct 27, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Oct 27, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Gagnon Robert E. | 2026-10-23 | S | Sale | 14000 | 3.5464 | 542,375 | 4 days | Filed terms
|
Common Stock
- Owner
- Gagnon Robert E.
- Date
- 2026-10-23
- Code
- S
- Action
- Sale
- Quantity
- 14000
- Price
- 3.5464
- Following holdings
- 542,375
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-23
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 14000
- transaction Price Per Share: 3.5464
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 542375
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Gagnon Robert E.: Chief Financial Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The shares reported on this line were sold were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 30, 2026. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Issuer. The shares sold cover tax withholding obligations that arose in connection with the vesting and settlement of restricted stock units. This transaction does not represent a discretionary trade by the Reporting Person.
- F2: The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $3.4449 to $3.79, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Original sources
Prepared automatically from public filing data. Report a correction.